StemVax Therapeutics
Business Services · Ohio, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
8584 Washington St 127, Chagrin Falls, O...Phone Number
(440) 644-1027Website
www.stemvax.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About StemVax Therapeutics
StemVax Therapeutics is a translational biotechnology company focused on developing novel immunotherapeutics for brain tumor patients, particularly those suffering from Glioblastoma. The company aims to create effective treatments targeting cancer stem cells and multi-resistant cancer cells. As a wholly-owned subsidiary of NovAccess Global, Inc., StemVax is dedicated to accelerating research and development through clinical trials to bring safe and efficacious therapies to market. Their commitment extends to improving the lives of Glioblastoma and other brain tumor patients through innovative immunotherapeutic approaches.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is StemVax Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
StemVax Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if StemVax Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once StemVax Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Check if StemVax Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at StemVax Therapeutics
Click to see if StemVax Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when StemVax Therapeutics launches new products
Earning: See what the market has to say on StemVax Therapeutics recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to StemVax Therapeutics
Compare insights from companies similar to StemVax Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
StemVax Therapeutics
<$5M
1-10
Private
-
2013
N/A
Company Profile Activity
Activity Insights
StemVax Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
StemVax Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about StemVax Therapeutics.
StemVax Therapeutics Tech Stack
A closer look at the technologies used by StemVax Therapeutics
See more technologies
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding StemVax Therapeutics
Sign Up For FreeTo access detailed company insights
StemVax Therapeutics is a translational biotechnology company focused on developing novel immunotherapeutics for brain tumor patients, particularly those suffering from Glioblastoma. The company aims to create effective treatments targeting cancer stem cells and multi-resistant cancer cells. As a wholly-owned subsidiary of NovAccess Global, Inc., S... Read More
